Assay News and Research

RSS

Transformative new approach for viral titer determination using xCELLigence RTCA

Accurate determination of viral titers is critical to vaccine development. Historically, titers have been determined using endpoint assays which are labor-intensive, expensive, and time-consuming. This is increasingly problematic in modern production facilities where bioprocess optimization is performed using high-throughput cell culture reactors that can produce batches of virus faster than they can be analyzed.

13 Mar 2018

Scientists develop novel assay for studying molecular determinants of bronchoconstriction/dilation

Contraction and relaxation of smooth muscle cells and fibroblasts within the bronchial airways dramatically affects airflow, and being able to modulate these processes is critical for treating asthma and allergic responses.

13 Mar 2018

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

In a research article published in EMBO Molecular Medicine, a group of scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.

13 Mar 2018

ACEA Biosciences develops novel assay for rapid identification of endocrine-disrupting chemicals

Endocrine-disrupting chemicals are substances that interfere with the ability of endogenous hormones to regulate homeostasis via their cognate nuclear receptors.

13 Mar 2018

Protein pathways linked to heart disease, diabetic complications identified in patients with diabetes

Protein pathways that are closely linked to changes in both triglyceride and hemoglobin A1c levels in diabetic patients have been identified in new research by the Intermountain Medical Center Heart Institute in Salt Lake City.

12 Mar 2018

Discovery may lead to effective research and better treatments for Ebola, other viral diseases

University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.

8 Mar 2018

Volition declares interim results from first asymptomatic CRC frontline screening study

VolitionRx Limited today announced interim results from its first asymptomatic colorectal cancer frontline screening study. This ongoing study is being carried out in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark and involves 680 subjects from the Danish National CRC Screening Program.

28 Feb 2018

Hamilton Robotics Launch ID NIMBUS® for Forensic Genomics Applications

Hamilton Robotics announce the release of the ID NIMBUS® assay ready workstation, specifically pre-configured and qualified to automate post-PCR sample processing using the Verogens renowned ForenSeq DNA Signature Prep Kit.

From Hamilton Process Analytics 26 Feb 2018

Highly sensitive ELISA method for analysis of CET in plasma samples

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.

23 Feb 2018

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.

22 Feb 2018

Using Smartphones for Cancer Diagnosis and Management

Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a “less is more” approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro’s research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.

From Pittcon 14 Feb 2018

Scientists develop new array to identify biomarkers for wide range of diseases

Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.

12 Feb 2018

NIH scientists modify new RT-QuIC assay to detect Parkinson's, dementia with Lewy bodies

National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson's disease and dementia with Lewy bodies.

9 Feb 2018

New FluChip-8G technology could aid in pandemic preparedness

InDevR Inc., a Boulder-based analytical technology and life science company, today announced plans to launch a Research Use Only version of their FluChip-8G technology to aid in pandemic preparedness.

6 Feb 2018

Cannabis Quality and Contamination Testing

Dr. Bob Clifford has published and presented over 125 papers in the fields of food, pharmaceutical, environmental, energy, geology, material science, photonics, and cannabis. However, his true love is in food. After graduating with his Ph.D., he left his job with the FDA for Shimadzu where he has worked for the last 26 years.

From Pittcon 5 Feb 2018

Assay News and Research

Transformative new approach for viral titer determination using xCELLigence RTCA

Scientists develop novel assay for studying molecular determinants of bronchoconstriction/dilation

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

ACEA Biosciences develops novel assay for rapid identification of endocrine-disrupting chemicals

Protein pathways linked to heart disease, diabetic complications identified in patients with diabetes

Discovery may lead to effective research and better treatments for Ebola, other viral diseases

Volition declares interim results from first asymptomatic CRC frontline screening study

Hamilton Robotics Launch ID NIMBUS® for Forensic Genomics Applications

Highly sensitive ELISA method for analysis of CET in plasma samples

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

Using Smartphones for Cancer Diagnosis and Management

Scientists develop new array to identify biomarkers for wide range of diseases

NIH scientists modify new RT-QuIC assay to detect Parkinson's, dementia with Lewy bodies

New FluChip-8G technology could aid in pandemic preparedness

Cannabis Quality and Contamination Testing

New organ-on-a-chip technology provides simple setting to study blood vessel formation

Eagle Biosciences launches novel Intact FGF23 ELISA Assay Kit

Leading medical societies update molecular testing guideline for lung cancer

Study shows value of occupational therapy in the lives of young adults with diabetes

Researchers develop single blood test that screens for 8 cancer types

Measuring Drug-Target Residence Times with Biochemical Assays eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News